Merck Frosst is introducing a new strength of Fosavance (alendronate sodium/cholecalciferol) that contains a higher amount of cholecalciferol (vitamin D3).
On October 4 at the National Conference of the Canadian Society of Association Executives (CSAE) in Vancouver, NDMAC was presented with the Associations Make a Better Canada award.
Therapure Biopharma Inc. launched with a pledge to provide Canadian biotech companies specializing in biological protein therapeutics with better access to the global market.
